Nuwellis announces closing of $5.0 million underwritten public offering including full exercise of overallotment option

Minneapolis, june 10, 2025 (globe newswire) -- nuwellis, inc. (nasdaq: nuwe) (“nuwellis” or the “company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“common stock”), pre-funded warrants to purchase 14,085,998 shares of common stock, in each case with accompanying series a warrants to purchase up to 49,999,995 shares of common stock and series b warrants to purchase up to 16,666,665 shares of common stock with gross proceeds of approximately $5.0 million, which includes the full exercise of the underwriter's over-allotment option to purchase additional shares and warrants.
NUWE Ratings Summary
NUWE Quant Ranking